Skip to main content
Log in

Identification, purification and characterization of matrix metalloproteinase-2 in bovine pulmonary artery smooth muscle plasma membrane

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Bovine pulmonary artery smooth muscle tissue possesses matrix metalloproteinase-2 (72 kDa gelatinase: MMP-2; E.C. 3.4.24.24) as revealed by immunoblot studies of its smooth muscle plasma membrane suspension with polyclonal MMP-2 antibody. In this report, we described the purification and partial characterization of MMP-2 in the plasma membrane fraction of the smooth muscle. MMP-2 has been purified from plasma membrane fraction of bovine pulmonary artery smooth muscle to homogeneity using a combination of purification steps. Heparin sepharose purified preparation of 72 kDa progelatinase is composed of two distinct population of zymogens: a 72 kDa progelatinase tightly complexed with TIMP-2 ∥an ambient tissue inhibitor of metalloprotease in the smooth muscle plasma membrane), and a native 72 kDa progelatinase free of any detectable TIMP-2. The homogeneity of the native 72 kDa progelatinase form is demonstrated by SDS-PAGE under nonreducing condition, nondenaturing native gel electrophoresis. The purified TIMP-2 free proenzyme electrophoresed as a single band of 72 kDa which could be activated by APMA with the formation of 62 and 45 kDa active species. The proenzyme is activated poorly by trypsin but not by plasmin. The purified 72 kDa progelatinase is stable at aqueous solution and does not spontaneously autoactivate. The purified 72 kDa gelatinase exhibited properties that are typical of MMP-2 obtained from other sources. These are: (i) its activity is dependent on the divalent cation, Ca2+, and is inhibited by EDTA, EGTA and 1:10-phenanthroline; (ii) it was inhibited by α2 macroglobulin but not by the inhibitors of serine, cysteine, thiol, aspartic proteinases and calpains; (iii) it was found to be inhibited by TIMP-2, the specific inhibitor of MMP-2; (iv) like MMP-2, obtained from other sources, its major substrates were found to be collagens (type IV and V) and gelatins (type I, IV and V). Additionally, the purified MMP-2 degrades Dnp-Pro-Gln-Gly-Ile-Ala-Gly-Gn-D-Arg-OH (dinitrophenyl labelled peptide), a well known synthetic substrate for the MMP-2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Woessner JF Jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145–2154, 1991

    Google Scholar 

  2. Lee AY, Akers KT, Collier M, Li L, Eisen AZ, Seltzer JL: Intracellular activation of gelatinase A (72-kDa type IV collagenase) by normal fibroblasts. Proc Natl Acad Sci USA 94: 4424–4429, 1997

    Google Scholar 

  3. Seltzer JL, Lee AY, Akers KT, Sudbeck B, Southon EA, Wayner EA, Eisen AZ: Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction. Exp Cell Res 213: 365–374, 1994

    Google Scholar 

  4. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7: 728–735, 1995

    Google Scholar 

  5. Ray JM, Stetler-Stevenson WG: The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 7: 2062–2072, 1994

    Google Scholar 

  6. Wang Z, Juttermann R, Soloway PD: TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 275: 26411–26415, 2000

    Google Scholar 

  7. Sternlicht MD, Werb Z: How matrix metalloproteases regulate cell behaviour. Annu Rev Cell Dev Biol 17: 463–516, 2001

    Google Scholar 

  8. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64: 327–336, 1991

    Google Scholar 

  9. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling (review). Trends Genet 6: 121–125, 1990

    Google Scholar 

  10. Murphy G, Sellers A: In: D.E. Wolley, J.M. Evanson (eds). Collagenases in Normal and Pathological Connective Tissues. Wiley, New York, 1980, pp 65–81

    Google Scholar 

  11. Springman EB, Angleton EL, Birkedal-Hansen H, Van Wart HE: Multiple modes of activation of latent human fibroblast collagenase: Evidence for the role of a Cys73 active-site zinc complex in latency and a ‘cysteine switch’ mechanism for activation. Proc Natl Acad Sci USA 87: 364–368, 1990

    Google Scholar 

  12. Van Wart HE, Birkedal-Hansen H: The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87: 5578–5582, 1990

    Google Scholar 

  13. Stetler-Stevenson WG, Krutzsch HC, Wacher MP, Margullies IM, Liotta LA: The activation of human type IV collagenase proenzyme. Sequence identification of the major conversion product following organomercurial activation. J Biol Chem 264: 1353–1356, 1989

    Google Scholar 

  14. Moll UM, Youngleib GL, Rosinski KB, Quigley JP: Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT 1080 tumor cells. Cancer Res 50:6162–6170, 1990

    Google Scholar 

  15. Stefansson S, Aimes RT, Seward NB, Alexander DS, Quigley JP: Native TIMP-free 70 kDa progelatinase (MMP-2) secreted at elevated levels by RSV transformed fibroblasts. J Cell Physiol 161: 419–428, 1994

    Google Scholar 

  16. Howard EW, Bullen EC, Banda MJ: Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J Biol Chem 266: 13064–13069, 1991

    Google Scholar 

  17. Murphy G, Willenbrock F, Ward RV, Cockett MI, Eaton D, Docherty AJP: The C-terminal domain of 72 kDa gelatinase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases. Biochem J 283: 637–641, 1992

    Google Scholar 

  18. Ward RV, Hembry RM, Reynolds JJ, Murphy G: The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1. Biochem J 278: 179–187, 1991

    Google Scholar 

  19. Goldberg GI, Marmer BL, Grant GA, Eisen AZ, Wilhelam S, He CS: Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteases designated TIMP-2. Proc Natl Acad Sci USA 86: 8207–8211, 1989

    Google Scholar 

  20. Chen JM, Aimes RT, Ward GR, Youngleib GL, Quigley JP: Isolation and characterization of a 70-kDa metalloprotease (gelatinase) that is elevated in Rous sarcoma virus-transformed chicken embryo fibroblasts. J Biol Chem 266: 5113–5121, 1991

    Google Scholar 

  21. Fridman R, Fuerst TR, Bird RE, Hoyhtya M, Oelkuct M, Kraus S, Komarek D, Liotta LA, Berman ML, Stetler-Stevenson WG: Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. J Biol Chem 267: 15398–15405, 1992

    Google Scholar 

  22. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H: Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 194: 721–730, 1990

    Google Scholar 

  23. Kolkenbrock H, Orgel D, Hecker-Kia A, Noack W, Ulbrich N: The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor. Eur J Biochem 198: 775–781, 1991

    Google Scholar 

  24. Roychoudhuri S, Ghosh SK, Chakraborti T, Chakraborti S: Role of hydroxyl radical in the oxidant H2O2-mediated Ca2+ release from pulmonary smooth muscle mitochondria. Moll Cell Biochem 159: 95–103, 1996

    Google Scholar 

  25. Das S, Chakraborti T, Mandal M, Mandal A, Chakraborti S: Role of membrane-associated Ca2+ dependent matrix metalloproteinase-2 in the oxidant activation of Ca2+ ATPase by tertiary butylhydroperoxide. Mol Cell Biochem 237: 85–93, 2002

    Google Scholar 

  26. Master BSS, Williams CH, Kamin H: The preparation and properties of microsomal TPNH cytocrhrome C reductase from pig liver. Meth Enzymol 10: 565–573, 1967

    Google Scholar 

  27. Wharton DC, Tzagoloff A: Cytochrome oxidase from beef heart mitochondria. In: Methods in Enzymology. Academic Press, New York, 1967, pp 10, 245, 249

    Google Scholar 

  28. Hodges TK, Leonard RT: Purification of a plasma membrane bound adenosin triphosphatase from plant roots. In: S. Fleischer, L. Packer (eds). Methods in Enzymology, 32, part B. Academic Press, New York, 1974, pp 396–397

    Google Scholar 

  29. Chen PS, Toribara TY, Warner H: Microdetermination of phosphorous. Anal Chem 28: 1756–1758, 1956

    Google Scholar 

  30. Zylinska L, Guerini D, Gromadzinska E, Lachowicz L: Protein kinases A and C phosphorylate purified Ca2+-ATPase from rat cortex, cerebellum and hippocampus. Biochim Biopys Acta 1448: 99–108, 1998

    Google Scholar 

  31. Englard S, Seifter S: Precipitation techniques. Meth Enzymol 182: 285–300, 1990

    Google Scholar 

  32. Triebel S, Blaser J, Gote T, Pelz G, Schuren E, Schmitt M, Tschesche H: Evidence for the tissue unhibitor of metalloproteinases-1 (TIMP-1) in human polymorphonuclear leukocytes. Eur J Biochem 231: 714–719, 1995

    Google Scholar 

  33. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophasge T4. Nature (Lond) 227: 680–685, 1970

    Google Scholar 

  34. Oakley BR, Kirsch DR, Morris NR: A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 105: 361–363, 1980

    Google Scholar 

  35. Brown PD, Kleiner DE, Unsworth EJ, Stetler-Stevenson WG: Cellular activation of the 72 kDa type IV procollagenase TIMP-2 complex. Kidney Int 43: 163–170, 1993

    Google Scholar 

  36. Billings PC, Haber JM, Liao DC, Tuttle SW: Human fibroblasts contain a proteolytic activity which is inhibited by the Bowman—Birk protease inhibitor. Cancer Res 51: 5539–5543, 1991

    Google Scholar 

  37. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci 76:4350–4354, 1979

    Google Scholar 

  38. Zhou H, Bernhard EJ, Fox FE, Billings PC: Induction of metalloproteinase activity in T-lymphocytes. Biochim Biophys Acta 1177: 174–178, 1993

    Google Scholar 

  39. Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJ: Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes. Biochem J 248: 265–268, 1987

    Google Scholar 

  40. Masui Y, Takemoto T, Sakakibara S, Hori H, Nagai Y: Synthetic substrates for vertebrate collagenase. Biochem Med 17: 215–221, 1977

    Google Scholar 

  41. David WW: In: Biostatistics: A foundation for analysis in health science. Wiley, New York, 1978, p 219

    Google Scholar 

  42. The lysosome concept: Ciba Symposiums on Lysosomes. In: A.V.S. de Reuck, M.P. Cameron (eds). Little, Brown, Boston, MA, 1963. pp 1–35

    Google Scholar 

  43. Ketis NV, Hoover RL, Karnovsky MJ: Isolation of bovine aortic endothelial cell plasma membranes: Identification of membrane associated cytoskeletal proteins. J Cell Physiol 128: 162–170, 1986

    Google Scholar 

  44. Clark ML, Lanz HC, Senior JR: Enzymatic distinction of rat intestinal cell brush border and endoplasmic reticular membranes. Biochem Biophys Acta 183: 233–238, 1969

    Google Scholar 

  45. Stetler-Stevenson WG, Krutzsch HC, Liotta LA: Tissue inhibitor of metalloproteinase (TIMP-2). A new member of the metalloproteinase inhibitor family. J Biol Chem 264: 17374–17378, 1989

    Google Scholar 

  46. Galis ZS, Kranzhofer R, Libby P: Thrombin promotes activation of matrix metalloproteinase-2 (MMP-2) produced by cultured smooth muscle cells. FASEB J 9: A413, 1995

    Google Scholar 

  47. Olson MW, Gervasi DC, Mobashery S, Fridman R: Kinetic analysis of the binding of human matrix metalloproteinase-2 and-9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J Biol Chem 272: 29975–29983, 1997

    Google Scholar 

  48. Chakraborti T, Das S, Mandal M, Mandal A, Chakraborti S: Role of Ca2+ dependent matrix metalloprotease-2 in stimulating Ca2+ATPase activity under peroxynitrite treatment in pulmonary vascular smooth muscle plasma membrane. IUBMB Life 53: 167–173, 2002

    Google Scholar 

  49. Mandal M, Chakraborti T, Das S, Mandal A, Chakraborti S: Matrix metalloprotease-2 mediated activation of Ca2+ATPase by superoxide radical (O 2 ) in plasma membrane of bovine pulmonary vascular smooth muscle. Indian J Biochem Biophys 39: 390–396, 2002

    Google Scholar 

  50. Rajagopalan S, Meng XP, Ramasamy S, Harrison DG, Galis ZS: Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J Clin Invest 98: 2572–2579, 1996

    Google Scholar 

  51. Mandal M, Das S, Chakraborti T, Mandal A, Chakraborti S: Role of the matrix metalloprotease-2 in the oxidant activation of Ca2+ATPase by hydrogen peroxide in pulmonary vascular smooth muscle plasma membrane. J Biosci 28: 205–213, 2003

    Google Scholar 

  52. Mellgren RL, Merieie MT, Lane RD: Proteolysis of the calcium dependent protease inhibitor by myocardial calcium-dependent protease. Arch Biochem Biophys 246: 233–239, 1986

    Google Scholar 

  53. Shum-Tim D, Stock U, Hrkach J, Shinoka T, Lien J, Moses MA, Stamp A, Taylor G, Moran AM, Landis W, Langer R, Vacanti JP, Mayer JE: Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg 68: 2298–2304, 1999

    Google Scholar 

  54. Frisdal E, Gest V, Vieillard-Baron A, Levame M, Lepetit H, Eddahibi S, Lafuma C, Harf A, Adnot S, Dortho MP: Gelatinase expression in pulmonary arteries during experimental pulmonary hypertension. Eur Respir J 18: 838–845, 2001

    Google Scholar 

  55. Yosef YB, Lahat N, Shapiro S, Bitterman H, Miller A: Regulation of endothelial matrix metalloproteinase-2 by hypoxia/reoxygenation. Circ Res 90: 784–791, 2002

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Das, S., Mandal, M., Mandal, A. et al. Identification, purification and characterization of matrix metalloproteinase-2 in bovine pulmonary artery smooth muscle plasma membrane. Mol Cell Biochem 258, 73–89 (2004). https://doi.org/10.1023/B:MCBI.0000012838.41792.d2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:MCBI.0000012838.41792.d2

Navigation